Carregant...
Regorafenib-Induced Hand–Foot Skin Reaction Is More Severe on the Feet Than on the Hands
Regorafenib is a multikinase inhibitor for the treatment of metastatic colorectal cancer. Regorafenib-induced hand–foot skin reaction (HFSR) is a common side effect during treatment. The reported frequency of HFSR was 80% (grade 3: 28%) in the Japanese subpopulation in the CORRECT trial; however, mo...
Guardat en:
| Publicat a: | Oncol Res |
|---|---|
| Autors principals: | , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Cognizant Communication Corporation
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7848261/ https://ncbi.nlm.nih.gov/pubmed/29914591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096504018X15291727589740 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|